Gesund is the world’s first compliant AI factory on a mission to help bring clinical-grade AI solutions to market. To help comply with regulatory requirements, our platform audits and validates 3rd party medical AI solutions for safety, effectiveness and equity. Backed by marquee investors including Merck, McKesson, Northpond and 500, Gesund orchestrates the entire AI/ML lifecycle for all stakeholders by bringing models, data and experts together in a no-code environment.

At Hertie, a leading European policy school, I teach a graduate course on deeptech entrepreneurship in highly regulated industries such as healthcare and energy.

caresyntax is working to make mission-critical health care settings such as surgery, interventional radiology and obstetrics smarter and safer. The company’s proprietary solutions leverage IoT, analytics and AI technologies to automate clinical and operational decision support for surgical teams, and support all outcome contributors in the delivery and management of risk-bearing contracts. By integrating data from medical devices, electronic health records, and other sources inside the OR into a unified data platform, caresyntax helps caregivers better identify and manage risk, increase workflow efficiency, reduce surgical variability and improve operational or clinical outcomes at the point of care. Today, caresyntax technologies are used in more than 7,000 operating rooms worldwide, and support surgical teams in over 10 million procedures per year.

EEme [acquired by Uplight, previously known as Tendril Inc.], a Carnegie Mellon University spin-out, strives to bring the scalable machine learning element to the utility industry leveraging its proprietary Disaggregation-as-a-Service energy efficiency intelligence platform.

Co-teaching a graduate-level course titled "New Technology Commercialization: Non-Market Public Policy Strategies for Entrepreneurs and Innovators" at the engineering school.

Young Entrepreneur fellow - early-stage venture due diligence and deal sourcing for Foundation Capital, a $2.5B Silicon Valley venture capital firm.

NVP, formerly Bell Labs' venture arm currently an independent venture capital firm, specializes in corporate spin-outs and has over $700M under management. Duties as a summer associate include early stage venture due diligence.

Worked with Center for Climate and Energy Decision Making (CEDM) and Carnegie Mellon Electricity Industry Center (CEIC). Past research includes assessment and communication of Enhanced Geothermal Systems (EGS) induced seismicity risk.

Techno-economic strategy consulting for multinational oil companies and institutions on up-, mid- and downstream levels.

Research project on reservoir modeling via neural networks.